[CAS NO. 23800-56-8] Pogostone
PRODUCTS SPECIFICATIONS [23800-56-8]
DESCRIPTION [23800-56-8]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 224.25 |
| Molecular Formula | C12H16O4 |
| SMILES | O=C1C(C(CCC(C)C)=O)=C(O)C=C(C)O1 |
Summary
Pogostone is isolated from patchouli oil with anti-bacterial and anti-cancer activities. Pogostone inhibits both gram negative and gram positive bacteria, also show inhibitory effect on corynebacterium xerosis with a MIC value of 0.098 µg/ml [2] . Pogostone induces cell apoptosis and autophagy [2] .
In Vitro
Pogostone shows inhibitory effects on HCT116 cell with an IC
50
value of 18.7±1.93 µg/ml, and show strikingly lower cytotoxicity on normal human embryonic kidney cell 293A (IC
50
: 95.13±19.44 µg/ml) and endothelial cell HUVEC (IC
50
: 112±20.77 µg/ml)
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Pogostone ( intraperitoneal injection; 25, 50 and 100 mg/kg) shows antibacterial activity in vivo against Escherichia coli (E. coli) and MRSA. Ninety percent of the mice infected with E. coil could be protected at the concentrations of 50 and 100 mg/kg, and 60% of the mice at 25 mg/kg, while the rate of protection for the mice infected with MRSA was 60% and 50% at doses of 100 and 50 mg/kg, respectively
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 100 mg/mL ( 445.93 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 4.4593 mL | 22.2965 mL | 44.5931 mL |
| 5 mM | 0.8919 mL | 4.4593 mL | 8.9186 mL |
| 10 mM | 0.4459 mL | 2.2297 mL | 4.4593 mL |
Synonyms